Delivery Order SPE2DB22D2007-SPE2DB24FJ2AM
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,885.78 firm fixed price delivery order contract to provide VYVANSE 30 MG CAPSULE 100S. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceutical products and medical supplies to various U.S. government agencies, primarily the Department of Defense. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $23,512.73 firm fixed price delivery order is for the supply of VYVANSE CAPS 50MG, a prescription medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is for the delivery of VYVANSE CAPS 60MG, a pharmaceutical product, with a ceiling value of $11,226.44 and a performance period through April 15, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $4,959.42, is for the delivery of 4564630210 - VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has a firm fixed price and is set to be completed by May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $1,129.08, was awarded by the Defense Logistics Agency (DLA) on July 19, 2024 and has a completion date of July 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564312355 - VYVANSE 50 MG CAPSULE 100S. The $7,494.53 firm fixed-price contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,724.00 firm fixed price delivery order is for VYVANSE 50 MG CAPSULE 100S, with a completion date of February 6, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $1,720.06, is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has a period of performance through June 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a ceiling value of $4,653.59 and is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. The contract is not set aside for any specific business type....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ2AMDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYVANSE 70 MG CAPSULE 100S. The contract, valued at $4,448.45, is a Firm Fixed Price Delivery Order with a completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will fulfill this order. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/30/24 |